San Diego Cardiac Center

San Diego, California 92123

5 studies enrolling now · 42 studies all time

What they study most

ASCVD, Acute Coronary Syndrome, Acute Decompensated Heart Failure (ADHF), Acute Myocardial Infarction (AMI), Atrial Fibrillation, Cardiac Failure, Cardio-pulmonary Bypass, Cardiovascular Disease, Cardiovascular Diseases, Cardiovascular Risk, Chronic Heart Failure, Congestive Heart Failure

Studies at this site

• Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention — Recruiting now
• A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System — Recruiting now
• Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction — Recruiting now
• Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity — Recruiting now
• ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack — Recruiting now
• A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF) — Recruiting now
• Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction — Recruiting now
• LUX-Dx TRENDS Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System. — Running, not enrolling
• A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients. — Running, not enrolling
• Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation — Running, not enrolling
• A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation — Running, not enrolling
• A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation — Running, not enrolling
• A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome — Completed
• AMPLATZER PFO Occluder Post Approval Study — Running, not enrolling
• Vein of Marshall Ethanol Infusion for Persistent Atrial Fibrillation — Completed
• Hemodynamic-GUIDEd Management of Heart Failure — Completed
• Assessment of Safety and Effectiveness in Treatment Management of Atrial Fibrillation With the BWI IRE Ablation System — Completed
• Changes in NT-proBNP, Safety, and Tolerability in HFpEF Patients With a WHF Event (HFpEF Decompensation) Who Have Been Stabilized and Initiated at the Time of or Within 30 Days Post-decompensation (PARAGLIDE-HF) — Completed
• AMPLATZER™ Amulet™ LAA Occluder Trial — Completed
• EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction) — Completed
• Study of Heart Failure Hospitalizations After Aquapheresis Therapy Compared to Intravenous (IV) Diuretic Treatment — Stopped early
• Evaluation of VISITAG SURPOINT™ Module With External Processing Unit (EPU) — Completed
• MOre REsponse on Cardiac Resynchronization Therapy With MultiPoint Pacing — Stopped early
• EntrestoTM (LCZ696) In Advanced Heart Failure (LIFE Study) — Completed
• The Cardiovascular Multi-dimensional Observational Investigation of the Use of PCSK9 Inhibitors (cvMOBIUS) — Stopped early
• Study Watch AF Detection At Home — Completed
• MultiPoint Pacing™ Post Market Study — Completed
• Cardiovascular Inflammation Reduction Trial — Completed
• Study Watch Atrial Fibrillation (AF) Detection Investigation — Completed
• SYMPLICITY HTN-3 Renal Denervation in Patients With Uncontrolled Hypertension — Completed
• Effect of Pexelizumab on All-Cause Mortality and Myocardial Infarction in Patients Undergoing Coronary Artery Bypass Graft Surgery With Cardio-Pulmonary Bypass — Completed
• NAVISTAR® THERMOCOOL® SF Catheter: Observational Study — Completed
• Efficacy and Safety Study of Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure — Completed
• Drug Compliance and Quality of Life in Patients With Heart Failure Dosed With Either Once-daily or Twice-daily Coreg — Completed
• User Performance Evaluation of the INRatio® Prothrombin Time (PT) Monitoring System With a New INRatio Test Strip Designed for Low Sample Volume and Heparin Insensitivity — Completed
• Evaluation of the Accuracy and Precision of the INRatio® Prothrombin Time (PT) Monitoring System With New INRatio Test Strip Designed for Low Sample Volume and Heparin Insensitivity — Completed
• Heart Failure (HF) Assessment With B-type Natriuretic Peptide (BNP) In The Home — Completed
• The WOMEN Study: What is the Optimal Method for Ischemia Evaluation in WomeN? — Completed
• EVEREST: Efficacy of Vasopressin Antagonism in hEart failuRE: Outcome Study With Tolvaptan — Completed
• Correlation Of Respiratory Rate Level And Trend Evaluation in Heart Failure Patients — Stopped early
• Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of Decompensated Chronic Heart Failure. — Completed
• Multicenter, Randomized, Double-Blind, Placebo Controlled, Efficacy Study on the Effects of Tolvaptan on Left Ventricular Dilatation in Congestive Heart Failure Patients — Completed